These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28990508)

  • 1. Biomarkers of Atrial Fibrillation in Hypertension.
    Tsioufis C; Konstantinidis D; Nikolakopoulos I; Vemmou E; Kalos T; Georgiopoulos G; Vogiatzakis N; Ifantis A; Konstantinou K; Gennimata V; Tousoulis D
    Curr Med Chem; 2019; 26(5):888-897. PubMed ID: 28990508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers in Atrial Fibrillation and Heart Failure.
    Oikonomou E; Zografos T; Papamikroulis GA; Siasos G; Vogiatzi G; Theofilis P; Briasoulis A; Papaioannou S; Vavuranakis M; Gennimata V; Tousoulis D
    Curr Med Chem; 2019; 26(5):873-887. PubMed ID: 28875838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation.
    Stanciu AE; Vatasescu RG; Stanciu MM; Serdarevic N; Dorobantu M
    Cytokine; 2018 Mar; 103():63-68. PubMed ID: 29324263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HOMOCYSTEINE AS A PROGNOSTIC MARKER OF ATRIAL REMODELING AND CLINICAL PICTURE IN PATIENTS WITH PAROXYSMAL AND PERSISTENT FORMS OF ATRIAL FIBRILLATION].
    Snezhitsky VA; Yatskevich ES; Doroshenko EM; Smirnov VY; Dolgoshey TS; Rubinsky AY
    Klin Med (Mosk); 2016; 94(1):16-22. PubMed ID: 27172716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of Atrial Cardiopathy and Atrial Fibrillation Detection on Mobile Outpatient Continuous Telemetry After Embolic Stroke of Undetermined Source.
    Sebasigari D; Merkler A; Guo Y; Gialdini G; Kummer B; Hemendinger M; Song C; Chu A; Cutting S; Silver B; Elkind MSV; Kamel H; Furie KL; Yaghi S
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1249-1253. PubMed ID: 28237125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial hypertension drives arrhythmia progression via specific structural remodeling in a porcine model of atrial fibrillation.
    Manninger M; Zweiker D; van Hunnik A; Alogna A; Prassl AJ; Schipke J; Zeemering S; Zirngast B; Schönleitner P; Schwarzl M; Herbst V; Thon-Gutschi E; Huber S; Rohrer U; Ebner J; Brussee H; Pieske BM; Heinzel FR; Verheule S; Antoons G; Lueger A; Mühlfeld C; Plank G; Schotten U; Post H; Scherr D
    Heart Rhythm; 2018 Sep; 15(9):1328-1336. PubMed ID: 29803020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of diverse platelet activation markers as indicators for left atrial thrombus in atrial fibrillation.
    Tarnowski D; Poitz DM; Plichta L; Heidrich FM; Wiedemann S; Ruf T; Mierke J; Löhn T; Jellinghaus S; Strasser RH; Ibrahim K; Pfluecke C
    Platelets; 2018 Jan; 29(1):41-47. PubMed ID: 28287031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity.
    Mahajan R; Lau DH; Brooks AG; Shipp NJ; Manavis J; Wood JP; Finnie JW; Samuel CS; Royce SG; Twomey DJ; Thanigaimani S; Kalman JM; Sanders P
    J Am Coll Cardiol; 2015 Jul; 66(1):1-11. PubMed ID: 26139051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease.
    Teh AW; Kistler PM; Lee G; Medi C; Heck PM; Spence SJ; Sparks PB; Morton JB; Kalman JM
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):232-8. PubMed ID: 21955090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive evaluation of reverse atrial remodeling after catheter ablation of atrial fibrillation by P wave dispersion.
    Fujimoto Y; Yodogawa K; Takahashi K; Tsuboi I; Hayashi H; Uetake S; Iwasaki YK; Hayashi M; Miyauchi Y; Shimizu W
    Heart Vessels; 2017 Nov; 32(11):1375-1381. PubMed ID: 28631077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors of sustained sinus rhythm and recurrent atrial fibrillation after a radiofrequency modified Maze procedure.
    Beukema WP; Sie HT; Misier AR; Delnoy PP; Wellens HJ; Elvan A
    Eur J Cardiothorac Surg; 2008 Oct; 34(4):771-5. PubMed ID: 18768326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers Associated with Atrial Fibrosis and Remodeling.
    Dilaveris P; Antoniou CK; Manolakou P; Tsiamis E; Gatzoulis K; Tousoulis D
    Curr Med Chem; 2019; 26(5):780-802. PubMed ID: 28925871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left Atrial Remodeling Mechanisms Associated with Atrial Fibrillation.
    Qiu D; Peng L; Ghista DN; Wong KKL
    Cardiovasc Eng Technol; 2021 Jun; 12(3):361-372. PubMed ID: 33650086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of P wave Dispersion and Tissue Doppler Imaging for Predicting Paroxysmal Atrial Fibrillation in Patients with Hypertension.
    Zhang X; Zeng W; Li Y; Hou D; Li X; Xu W
    Heart Surg Forum; 2018 Feb; 21(1):E054-E058. PubMed ID: 29485966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse Fibrosis Architecture and Premature Stimulation Facilitate Initiation of Reentrant Activity Following Chronic Atrial Fibrillation.
    Angel N; Li LI; Macleod RS; Marrouche N; Ranjan R; Dosdall DJ
    J Cardiovasc Electrophysiol; 2015 Dec; 26(12):1352-60. PubMed ID: 26249367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension and Atrial Fibrillation: An Intimate Association of Epidemiology, Pathophysiology, and Outcomes.
    Dzeshka MS; Shahid F; Shantsila A; Lip GYH
    Am J Hypertens; 2017 Aug; 30(8):733-755. PubMed ID: 28338788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial sphericity: a new method to assess atrial remodeling. Impact on the outcome of atrial fibrillation ablation.
    Bisbal F; Guiu E; Calvo N; Marin D; Berruezo A; Arbelo E; Ortiz-Pérez J; de Caralt TM; Tolosana JM; Borràs R; Sitges M; Brugada J; Mont L
    J Cardiovasc Electrophysiol; 2013 Jul; 24(7):752-9. PubMed ID: 23489827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NT Pro-BNP can be used as a risk predictor of clinical atrial fibrillation with or without left atrial enlargement.
    Zhao X; Li H; Liu C; Ren Y; Sun C
    Clin Cardiol; 2022 Jan; 45(1):68-74. PubMed ID: 34952980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial apoptosis and fibrosis adversely affect atrial conduit, reservoir and contractile functions.
    Gasparovic H; Cikes M; Kopjar T; Hlupic L; Velagic V; Milicic D; Bijnens B; Colak Z; Biočina B
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):223-30; discussion 230. PubMed ID: 24722519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of left atrial function and left atrial enhancement in patients with atrial fibrillation: cardiac magnetic resonance study.
    Habibi M; Lima JA; Khurram IM; Zimmerman SL; Zipunnikov V; Fukumoto K; Spragg D; Ashikaga H; Rickard J; Marine JE; Calkins H; Nazarian S
    Circ Cardiovasc Imaging; 2015 Feb; 8(2):e002769. PubMed ID: 25652181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.